Plasma sFlt-1 Fluctuations in Response to Pulmonary Arterial Hypertension Treatment

Cardiovascular Pharmacology: Open Access
doi 10.4172/2329-6607.1000207
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Treatment of Pulmonary Arterial Hypertension in Pregnancy

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2007English

Surgical Treatment of Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2010English

Mortality-Related Risk Factors in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension. The Importance of Response to Treatment

Open Journal of Respiratory Diseases
2012English

Response to ‘Pulmonary Arterial Hypertension: An Update’ by M. Correale ()

Netherlands Heart Journal
Cardiovascular MedicineCardiology
2012English

Assessing Response to Therapy in Idiopathic Pulmonary Arterial Hypertension: A Consensus Survey of Canadian Pulmonary Hypertension Physicians

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2011English

Clinical Significance of Plasma Endothelin-1 Level After Bosentan Administration in Pulmonary Arterial Hypertension

Journal of Cardiology
Cardiovascular MedicineCardiology
2009English

Pulmonary Arterial Hypertension

Current Problems in Cardiology
MedicineCardiovascular MedicineCardiology
2011English

Epoprostenol Treatment for Idiopathic Pulmonary Arterial Hypertension in Pregnancy

Journal of Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2010English

Palliative Care in Pulmonary Arterial Hypertension: An Underutilised Treatment

European Respiratory Review
PulmonaryRespiratory Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy